GlobeImmune Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Overallotment Option
August 13, 2014
LOUISVILLE, Colo., July 8, 2014 (GLOBE NEWSWIRE) — GlobeImmune, Inc. (Nasdaq:GBIM), today announced the closing of its previously announced initial public offering of 1,725,000 shares of its common stock at a price to the public of $10.00 per share, which … Continue reading